Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03289000 · ClinicalTrials.gov registry record
A Retrospective Study to Evaluate the ConforMIS iTotal® Posterior Stabilized (PS) Knee Replacement System
A clinical trial, sponsored by Restor3D.
- Completed
- Registry status
- 93
- Enrollment target
NCT03289000: Completed study, sponsored by Restor3D.
NCT03289000 is a clinical trial that has completed, run by Restor3D. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03289000 has completed, sponsored by Restor3D.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
This study is a retrospective, multi-center study, with one single remote follow up contact. This study will include a minimum of 80 patients and a maximum 100 patients who have been treated with the ConforMIS iTotal PS knee product.
Primary Outcome
Demographics and medical history gathered from medical records
Interventions
- DEVICE iTotal Posterior Stabilized (PS) Knee Replacement System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2017-12-31 |
What the finished NCT03289000 record still lists
NCT03289000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 93 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which iTotal Posterior Stabilized (PS) Knee Replacement System is the first listed.
NCT03289000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03289000 about?
NCT03289000 is a clinical study titled "A Retrospective Study to Evaluate the ConforMIS iTotal® Posterior Stabilized (PS) Knee Replacement System". This study is a retrospective, multi-center study, with one single remote follow up contact. This study will include a minimum of 80 patients and a maximum 100 patients who have been treated with the ConforMIS iTotal PS knee product.
What is the current status of trial NCT03289000?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2017-04-24. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT03289000?
The interventions under investigation include: iTotal Posterior Stabilized (PS) Knee Replacement System (DEVICE).
Who is sponsoring clinical trial NCT03289000?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI